New York – (business wire) — The Pershing Square Foundation today announced MIND (“Maximizing Innovation in Neuroscience Discovery”) Award. With the launch of the award, the Foundation seeks to change the paradigm of neuroscience research by creating a community of thinkers on the next frontier that can unlock a deeper understanding of the brain and cognition.Basic Science Research Breakthroughs in and translational research bring important tools and knowledge about neurodegenerative diseases such as Alzheimer’s disease and dementia that affect millions of people worldwide. This award brings together the most talented early to mid-career researchers in the scientific field with creative and experimental ideas to solve problems that are changing our current understanding of the brain and its effects on human health. increase.
The MIND Prize fosters new interdisciplinary and transdisciplinary research by facilitating collaboration among academic departments and institutions, academia, the biomedical industry, philanthropy, and the business community. These breakthroughs in fundamental and foundational research will help strengthen our toolkit and knowledge of neurodegenerative and neurocognitive disorders. Each winner will receive $750,000, with $250,000 per year distributed over her three years.
“The Pershing Square Thon Award, which recognizes young researchers in cancer research, recognizes the truly innovative and innovative nature of the field by supporting early-career scientists at a time when funding would otherwise be difficult to come by. It was founded almost 10 years ago on the premise that it could lead to significant research. said Bill Ackman, joint trustee of the Pershing Square Foundation. “The success of our cancer awards made us realize that the award model can also be applied to cognitive health. We are therefore very pleased to launch the MIND Awards in our quest for breakthroughs in our understanding of the brain. ”
“Our brain is the gateway to our sense of self. Author of our memories and dreams and holds the key to consciousness. With 600 neurological disorders that affect about 50 million Americans each year, imagine a hopeful future in which we all escape the decline of neurodegenerative diseases,” Pershing said. Neri Oxman, joint trustee of the Square Foundation, said.According to Dickinson, the awards will begin with a sense of urgency and faith in the leaders who are committed to understanding and protecting organs wider than the sky. ”
Applicants must have 1 to 10 years of experience operating their own laboratory by the award start date (May 2023) and hold a Ph.D., MD, or MD-PhD (or equivalent). and must be affiliated with a U.S. research institution. American state.Deadline for submission of letter of intent December 12, 2022 5:00 p.m. ET. For more information on the MIND Prize and the application process, including full eligibility criteria, please visit https://pershingsquarefoundation.org/portfolio-organization/mind-prize/.
“Bold and innovative projects need funding at an early stage,” said Olivia Tournay Flatto, Ph.D., president of the Pershing Square Foundation and co-founder and executive director of the Pershing Square Son Cancer Research Alliance. says. “This initiative will break down barriers across disciplines and foster exciting and transformative discoveries in the human brain, leading to a transformative understanding of Alzheimer’s and other neurodegenerative diseases and, ultimately, cures. ”
“Dr. Rusty Gage, president and professor of the Salk Institute and member of the MIND Prize Advisory, said: board. “I believe the Pershing Square Foundation’s MIND Awards are a timely and important initiative to close this funding gap and target one of the most important challenges we face. ”
of mind award We are proud to rely on the guidance of our highly skilled Scientific Advisory Board (information) include:
Dr. Paola Arlotta Golub Family Professor and Chair of Stem Cell and Regenerative Biology, Harvard University
Richard Axel, M.D. Nobel laureate; co-director of the Mortimer B. Zuckerman Mind Brain Behavior Institute at Columbia University. Professor at Columbia University.Research Fellow, Howard Hughes Medical Institute
Dr. Cori Bergman, Torsten N. Wiesel Professor of Genetics & Genomics and Neuroscience & Behavior, Director of the Lulu and Anthony Wang Institute for Neural Circuits and Behavior, The Rockefeller University
Dr. Ed Boyden Y. Eva Tan Professor of Neurotechnology in the Brain and Cognitive Sciences Division at MIT. Massachusetts Institute of Technology McGovern Brain Institute.Research Fellow, Howard Hughes Medical Institute
Dr. Ali Brivanlow Professor Robert & Harriet Heilbrunn, Head of the Laboratory of Stem Cell Biology and Synthetic Embryology, The Rockefeller University. Co-Founder, Rumi Scientific Inc.
Dr. Navdeep Shandel David W. Cugell Professor of Medical Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine
Dr. Moses Chao Professor of Cell Biology, Physiology and Neuroscience, Psychiatry, New York University Langone School of Medicine
Juan Enriquez Managing Director of Excel Venture Management.Best-selling author; TED All-Star
Fred “Rusty” Gage, PhD, The Salk Institute for Biological Studies, Laboratory of Genetics, President and Chair of Research on Age-Related Neurodegenerative Diseases Vi and John Adler
Richard Isaacson, M.D. Director of the Brain Health Center. Director of the Alzheimer’s Disease Prevention Clinic at the Charles E. Schmidt School of Medicine at Florida Atlantic University. Associate Professor of Neurology, Weill Cornell Medicine
Serge Pasca, M.D. Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences, Bonnie Uytengsu and Family Director of the Stanford University Brain Organogenesis Program
Dr. James Rothman, Nobel Laureate; Sterling Professor of Cell Biology;Chair, Cell Biology; Professor of Chemistry; Director of the Yale Institute of Nanobiology
Dr. Bernardo Sabatini, M.D.Alice and Rodman W. Moorhead III Professor of Neurobiology, Harvard Medical School
Dr. Joshua Sains, Jeff Tarr Professor of Molecular and Cell Biology.Founding Director, Brain Science Center, Harvard University
Dr. Beth Stevens, HHMI investigator; member of the Broad Institute at MIT and Harvard; Lavine Family Research Chair, FM Kirby Center for Neurobiology, Boston Children’s Hospital
Dr. Bruce Stillman, Cold Spring Harbor Laboratory President and CEO
Dr. Stacey Wenninger Governor, FBRI
George Yankopoulos, MD, PhD, Regeneron President and Chief Scientific Officer
Dr. Michael Young, Nobel Laureate; Vice Chancellor for Academic Affairs, Professor Richard and Jeanne Fisher, Head of Genetics Laboratory, Rockefeller University
About the Pershing Square Foundation:
The Pershing Square Foundation (PSF) is a family foundation founded in 2006 that supports outstanding leaders and innovative organizations that address critical social issues and create scalable and sustainable global impact. . PSF has made over $600 million in grants and social investments in targeted areas such as health and medicine, education, economic development and social justice. Bill Ackman and Neri Oxman are co-directors of the Foundation. For more information, please visit www.pershingsquarefoundation.org.
